<DOC>
	<DOCNO>NCT00593294</DOCNO>
	<brief_summary>Oral contraceptive therapy routinely use treatment menstrual disturbance patient polycystic ovary syndrome ( PCOS ) . To date , cardiovascular risk ( CVR ) oral contraceptive ( OC ) know data available CVR PCOS patient treat OC physical exercise . The purpose study compare effect OC physical exercise CVR PCOS woman show hormonal metabolic effect two different treatment . We hypothesize physical exercise beneficial effect OC therapy hormonal metabolic feature PCOS woman less cardiovascular consequence .</brief_summary>
	<brief_title>Oral Contraceptive Cardiovascular Risk PCOS</brief_title>
	<detailed_description>One hundred fifty PCOS woman enrol . The diagnosis PCOS make base accord Rotterdam criterion ( 1 ) . Specifically , patient anovulation clinical and/or biochemical hyperandrogenism enrol . Patients randomly allocate three group ( OC , physical exercise placebo group ) use computer-software . Fifty PCOS patient treat OC ( Drospirenone 3 mg , Ethynylestradiol 30 microgram = Yasmin , Schering , Milan , Italy ) fifty PCOS undergone physical exercise , whereas fifty treat placebo tablet ( one tablet daily ; placebo group ) . The duration treatment 6 month . Patients treat OC instruct follow usual diet physical activity , whereas patient undergone physical exercise instruct follow detailed regular physical training program diet advise quality food eat . All subject nonsmoker none drink alcoholic beverage . Each subject undergo follow-up visit ( three 6 month treatment start ) treatment ( three 6 month treatment withdrawal ) . At follow-up visit , subject operator perform clinical , hormonal , metabolic cardiovascular assessment carotid brachial artery US</detailed_description>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>Polycystic ovary syndrome Age &lt; 18 &gt; 40 year BMI high 30 low 18 Pregnancy Hypothyroidism , hyperprolactinemia , Cushing 's syndrome , nonclassical congenital adrenal hyperplasia , use OC , glucocorticoid , antiandrogens , ovulation induction agent , antidiabetic antiobesity drug hormonal drug within previous 6 month Subjects neoplastic , metabolic ( include glucose intolerance ) , hepatic , cardiovascular disorder concurrent medical illness ( i.e . diabetes , renal disease , malabsorptive disorder , cephalea )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>PCOS</keyword>
	<keyword>oral contraceptive</keyword>
	<keyword>physical exercise</keyword>
	<keyword>CVR</keyword>
</DOC>